Generation of novel broad spectrum

Ended Definitive Contract Awarded Aug 16, 2006 Last action Oct 21, 2014

Award facts

Contract value 78% obligated: $28,041,647.00 Current and potential, with all options
Completion date 100% complete: Feb 28, 2011 Current and potential, with all options
NAICS code: Not on record
PSC: AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside: No set-aside
Competition: Full and Open Competition · 130 offers Basic Research
Pricing: Cost Plus Fixed Fee
Place of performance: Gaithersburg, MD 20878, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Close Out P00013	-$410,518	Oct 21, 2014
Terminate for Convenience P00012	$0	Mar 10, 2011
Funding Only Action P00011	$670,000	Feb 11, 2011
Funding Only Action P00010 · Generation of novel broad spectrum antiviral compounds against hemorrhagic fever viruses r & d effort.	$1,000,000	Dec 21, 2010
Other Administrative Action P00009 · Pharmaceutical r & d to develop medical countermeasures.	$2,346,417	Jul 26, 2010
Funding Only Action P00008	-$2,346,417	Jun 2, 2010
Funding Only Action P00007 · Incremental funding MOD	$4,346,417	Mar 23, 2010
Funding Only Action P00006	$6,275,171	Dec 12, 2008
Funding Only Action P00005	$5,400,651	Feb 4, 2008
Other Administrative Action P00004	$0	Oct 2, 2007
Funding Only Action P00003	$1,366,683	Jul 23, 2007
Other Administrative Action P00002	$0	Mar 7, 2007
Other Administrative Action P00001	$0	Dec 14, 2006
Original award	$3,086,010	Aug 16, 2006

Show all 14

HDTRA106C0035 was awarded to Functional Genetics, Inc. by Defense Threat Reduction Agency (Department of Defense) on August 16, 2006.

The government has obligated $21,734,414 on HDTRA106C0035. Its current value, with exercised options, is $28,041,647.

The extent of competition for HDTRA106C0035 was full and open competition. The government received 130 offers.

On GovTribe

Try for free Login